Allosteric Modulation of M1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking

被引:28
|
作者
Yeatman, Holly R. [1 ]
Lane, J. Robert [1 ]
Choy, Kwok Ho Christopher [1 ]
Lambert, Nevin A. [2 ]
Sexton, Patrick M. [1 ]
Christopoulos, Arthur [1 ]
Canals, Meritxell [1 ]
机构
[1] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Fac Pharm & Pharmaceut Sci, Melbourne, Vic 3052, Australia
[2] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
基金
英国医学研究理事会;
关键词
Allosteric Regulation; Arrestin; G Protein-coupled Receptor (GPCR); Receptor Endocytosis; Trafficking; GPCR Regulation; Allosteric Modulator; PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN; KINASE; PHOSPHORYLATION; ENDOCYTOSIS; LIGANDS; SEQUESTRATION; PHARMACOLOGY; SELECTIVITY; MECHANISMS;
D O I
10.1074/jbc.M113.536672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Allosteric modulators are an attractive approach to achieve receptor subtype-selective targeting of G protein-coupled receptors. Benzyl quinolone carboxylic acid (BQCA) is an unprecedented example of a highly selective positive allosteric modulator of the M-1 muscarinic acetylcholine receptor (mAChR). However, despite favorable pharmacological characteristics of BQCA in vitro and in vivo, there is limited evidence of the impact of allosteric modulation on receptor regulatory mechanisms such as -arrestin recruitment or receptor internalization and endocytic trafficking. In the present study we investigated the impact of BQCA on M-1 mAChR regulation. We show that BQCA potentiates agonist-induced -arrestin recruitment to M-1 mAChRs. Using a bioluminescence resonance energy transfer approach to monitor intracellular trafficking of M-1 mAChRs, we show that once internalized, M-1 mAChRs traffic to early endosomes, recycling endosomes and late endosomes. We also show that BQCA potentiates agonist-induced subcellular trafficking. M-1 mAChR internalization is both -arrestin and G protein-dependent, with the third intracellular loop playing an important role in the dynamics of -arrestin recruitment. As the global effect of receptor activation ultimately depends on the levels of receptor expression at the cell surface, these results illustrate the need to extend the characterization of novel allosteric modulators of G protein-coupled receptors to encapsulate the consequences of chronic exposure to this family of ligands.
引用
收藏
页码:15856 / 15866
页数:11
相关论文
共 50 条
  • [1] Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
    Abdul-Ridha, Alaa
    Lopez, Laura
    Keov, Peter
    Thal, David M.
    Mistry, Shailesh N.
    Sexton, Patrick M.
    Lane, J. Robert
    Canals, Meritxell
    Christopoulos, Arthur
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) : 6067 - 6079
  • [2] Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor
    Espinoza-Fonseca, LM
    Trujillo-Ferrara, JG
    [J]. FEBS LETTERS, 2005, 579 (30) : 6726 - 6732
  • [3] Regulation of the M1 muscarinic acetylcholine receptor by orthosteric and allosteric ligands
    Thomas, R.
    Langmead, C.
    Wood, M.
    Challiss, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 28 - 28
  • [4] Development of a Photoactivatable Allosteric Ligand for the M1 Muscarinic Acetylcholine Receptor
    Davie, Briana J.
    Sexton, Patrick M.
    Capuano, Ben
    Christopoulos, Arthur
    Scammells, Peter J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2014, 5 (10): : 902 - 907
  • [5] Contrasting Effects of Allosteric and Orthosteric Agonists on M1 Muscarinic Acetylcholine Receptor Internalization and Down-regulation
    Thomas, Rachel L.
    Langmead, Christopher J.
    Wood, Martyn D.
    Challiss, R. A. John
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03): : 1086 - 1095
  • [6] Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor
    Jakubík, J
    Tucek, S
    El-Fakahany, EE
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1033 - 1041
  • [7] Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
    Ma, Lei
    Seager, Matthew
    Wittmann, Marion
    Jacobson, Marlene
    Bickel, Denise
    Burno, Maryann
    Jones, Keith
    Graufelds, Valerie Kuzmick
    Xu, Guangping
    Pearson, Michelle
    McCampbell, Alexander
    Gaspar, Renee
    Shughrue, Paul
    Danziger, Andrew
    Regan, Christopher
    Flick, Rose
    Pascarella, Danette
    Garson, Susan
    Doran, Scott
    Kreatsoulas, Constantine
    Veng, Lone
    Lindsley, Craig W.
    Shipe, William
    Kuduk, Scott
    Sur, Cyrille
    Kinney, Gene
    Seabrook, Guy R.
    Ray, William J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) : 15950 - 15955
  • [8] Differential Regulation of the M1 Muscarinic Acetylcholine Receptor by Orthosteric and Allosteric Ligands
    Thomas, Rachel
    Langmead, Christopher
    Wood, Martyn
    Challiss, John
    [J]. FASEB JOURNAL, 2008, 22
  • [9] Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
    Mistry, Shailesh N.
    Lim, Herman
    Joerg, Manuela
    Capuano, Ben
    Christopoulos, Arthur
    Lane, J. Robert
    Scammells, Peter J.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2016, 7 (05): : 647 - 661
  • [10] Synthesis and pharmacological evaluation of irreversible allosteric ligands for the M1 muscarinic acetylcholine receptor
    Davie, B. J.
    Valant, C.
    Capuano, B.
    Scammells, P. J.
    Christopoulos, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S287 - S288